| Oct 15 |
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
|
| Oct 15 |
Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook
|
| Oct 15 |
Johnson & Johnson in charts: Innovative Medicine recorded highest sales in Q3
|
| Oct 15 |
Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M
|
| Oct 15 |
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
|
| Oct 14 |
How to play biotech stocks: Johnson & Johnson, Pfizer
|
| Oct 14 |
Bank of America, Q3 earnings, Fedspeak: What to Watch
|
| Oct 14 |
Johnson & Johnson Q3 Preview: Decline in profit is in the cards
|
| Oct 14 |
Q3 Earnings Results of U.S. Corporate Giants in Focus
|
| Oct 14 |
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
|
